Literature DB >> 11852961

Metabolic basis of drug interactions in the intensive care unit.

D S Streetman1.   

Abstract

Drug interactions are a potentially hazardous consequence of drug therapy, particularly in the critically ill. Many drug interactions result from changes in drug metabolism. These interactions can result in either an increase in toxicity or a decrease in effect. The process of normal drug metabolism depends on the activity of individual metabolizing enzymes. The activity of these enzymes can be altered by many factors, and it is alterations in these enzymes that account for most drug interactions. This article reviews normal and abnormal drug metabolism and discusses how this knowledge can be used to predict and prevent potential drug interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11852961     DOI: 10.1097/00002727-200002000-00002

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  4 in total

1.  Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US.

Authors:  Pamela L Smithburger; Sandra L Kane-Gill; Amy L Seybert
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

Review 2.  Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4.

Authors:  Stéphane Mouly; Christophe Meune; Jean-François Bergmann
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

Review 3.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 4.  Acute kidney injury induced by antimicrobial agents in the elderly: awareness and mitigation strategies.

Authors:  Fumihiro Mizokami; Tomohiro Mizuno
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 4.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.